CN Patent

CN101228138B — 神经治疗吡咯化合物

Assigned to SK Biopharmaceuticals Co Ltd · Expires 2012-11-21 · 13y expired

What this patent protects

描述了包含氨基甲酰基的吡咯化合物及其药学上可用的盐。该化合物是有效的抗惊厥剂，可用来治疗中枢神经系统疾病，特别是焦虑症、抑郁症、惊厥症、癫痫症、偏头痛、双相性精神障碍、药物滥用、抽烟病、ADHD、肥胖症、睡眠障碍、神经性疼痛、认知缺陷、神经变性、中风和肌肉痉挛。

USPTO Abstract

描述了包含氨基甲酰基的吡咯化合物及其药学上可用的盐。该化合物是有效的抗惊厥剂，可用来治疗中枢神经系统疾病，特别是焦虑症、抑郁症、惊厥症、癫痫症、偏头痛、双相性精神障碍、药物滥用、抽烟病、ADHD、肥胖症、睡眠障碍、神经性疼痛、认知缺陷、神经变性、中风和肌肉痉挛。

Drugs covered by this patent

Patent Metadata

Patent number
CN101228138B
Jurisdiction
CN
Classification
—
Expires
2012-11-21
Drug substance claim
No
Drug product claim
No
Assignee
SK Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.